Cargando…
mTOR inhibition acts as an unexpected checkpoint in p53-mediated tumor suppression
Here, we showed that the acetylation-defective p53-4KR mice, lacking the ability of cell cycle arrest, senescence, apoptosis, and ferroptosis, were tumor prone but failed to develop early-onset tumors. By identifying a novel p53 acetylation site at lysine K136, we found that simultaneous mutations a...
Autores principales: | Kon, Ning, Ou, Yang, Wang, Shang-Jui, Li, Huan, Rustgi, Anil K., Gu, Wei |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Cold Spring Harbor Laboratory Press
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7778266/ https://www.ncbi.nlm.nih.gov/pubmed/33303641 http://dx.doi.org/10.1101/gad.340919.120 |
Ejemplares similares
-
As expected, based on rapamycin-like p53-mediated gerosuppression, mTOR inhibition acts as a checkpoint in p53-mediated tumor suppression
por: Blagosklonny, Mikhail V.
Publicado: (2022) -
p53 suppresses carcinoma progression by inhibiting mTOR pathway activation
por: Akeno, Nagako, et al.
Publicado: (2014) -
Decision-making by p53 and mTOR
por: Maki, Carl G.
Publicado: (2010) -
Suppression of mTOR pathway and induction of autophagy-dependent cell death by cabergoline
por: Lin, Shao Jian, et al.
Publicado: (2015) -
The Paradox of Akt-mTOR Interactions
por: Vadlakonda, Lakshmipathi, et al.
Publicado: (2013)